Fever News and Research

RSS

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Pfizer Inc. said today that the United States District Court for the District of Delaware ruled that Pfizer's patent covering a method for using sirolimus, the active ingredient in RAPAMUNE®, for the inhibition of organ transplant rejection is valid and infringed.

31 Jan 2013

Genentech announces positive results from GA101 plus chlorambucil Phase III study on CLL

Genentech, a member of the Roche Group, today announced positive results from Stage 1 of CLL11, a Phase III randomized study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil chemotherapy compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL).

31 Jan 2013

Top ten tips for keeping bed bugs at bay

Bed bugs are on the rise and $1,000 per day ordinances are being suggested in cities like Chicago to enforce combat of the pests. "Know thy enemy," says Jorge Parada, MD, medical director, infection control, Loyola University Health System. "There are lots of myths out there about bed bugs and people may be getting caught up over nothing."

30 Jan 2013

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for KYNAMROTM (mipomersen sodium) injection.

30 Jan 2013

Viewpoints: Gov. Jindal calls Medicaid an 'outdated model;' GOP's opposition to 'Big Government' hurts effort to revamp entitlements

As the implementation of Obamacare unfortunately nears, every governor must decide whether to expand Medicaid. This is not a simple question. Expanding Medicaid will significantly burden state budgets across the country.

29 Jan 2013

Dengue fever mosquitoes tap into domestic networks of humans, along with their bloodstreams

The mosquitoes that spread dengue fever tap into the domestic networks of humans, along with their bloodstreams, finds a study recently published in the Proceedings of the National Academy of Sciences (PNAS).

28 Jan 2013

FDA approves Pfizer’s Prevnar 13 to prevent pneumococcal disease in older children, adolescents

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the expansion of the company's pneumococcal conjugate vaccine, Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), for use in older children and adolescents aged 6 years through 17 years for active immunization for the prevention of invasive disease caused by the 13 Streptococcus pneumoniae serotypes contained in the vaccine.

28 Jan 2013

Results from Amgen’s Neulasta plus bevacizumab Phase 3 trial on colorectal cancer

Amgen announced today results from Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES), a Phase 3 trial which evaluated Neulasta (pegfilgrastim) in 845 patients receiving FOLFOX or FOLFIRI and bevacizumab for the first-line treatment of locally-advanced or metastatic colorectal cancer.

28 Jan 2013

Periodontal health influences stem cell transplant success

Periodontal infection can increase the risk for developing bacteremia during the neutropenic phase of allogeneic hematopoietic stem cell transplantation, research suggests.

25 Jan 2013

Emerging tick-borne disease reaches USA

A new tick-borne infection caused by the spirochete bacteria Borrelia miyamotoi that produces similar symptoms to Lyme disease has been confirmed in a small number of patients in the USA.

25 Jan 2013

Gastrointestinal, liver effects common after doxycycline in cats

Doxycycline, an antibiotic derivative of tetracycline, commonly results in adverse gastrointestinal side effects and increased liver enzyme activity in cats, report German researchers.

25 Jan 2013

Subsidised antimalarial drugs: an interview with Kara Hanson

Artemisinin-based combination therapies (ACTs) are the currently recommended drugs for treating malaria. However, they are expensive, which limits their affordability. This means that people with malaria are likely to buy cheaper, less effective antimalarials such as chloroquine and sulphadoxine-pyrimethamine; or to simply buy painkillers and antipyretics.

25 Jan 2013

Ibuprofen and naproxen can cause kidney damage in children

Sick children, especially those with some dehydration from flu or other illnesses, risk significant kidney injury if given drugs such as ibuprofen and naproxen, Indiana University School of Medicine researchers said Friday.

25 Jan 2013

NSAIDs cause acute kidney injury in some children

Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, are commonly used to treat pain and reduce fever in children. However, the use of NSAIDs has been shown to cause acute kidney injury (AKI) in some children

25 Jan 2013

Brazilian city declares health emergency due to dengue fever outbreak

"Municipal authorities in Campo Grande, the capital of the southwestern Brazilian state of Mato Grosso do Sul, on Monday declared a health emergency due to a serious outbreak of dengue fever," Fox News Latino reports.

24 Jan 2013

NIH's candidate vaccine safe in treating dengue

A candidate dengue vaccine developed by scientists at the National Institutes of Health (NIH) has been found to be safe and to stimulate a strong immune response in most vaccine recipients, according to results from an early-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The trial results were published online on January 17 in the Journal of Infectious Diseases.

23 Jan 2013

Twitter posts could help health officials track disease outbreaks

This flu season you've probably seen a number of friends on social media talking about symptoms. New research from Brigham Young University says such posts on Twitter could actually be helpful to health officials looking for a head start on outbreaks.

23 Jan 2013

FDA approves Allergan’s BOTOX to treat overactive bladder

Allergan, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BOTOX (onabotulinumtoxinA) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency in adults who have had an inadequate response to or are intolerant of an anticholinergic medication.

19 Jan 2013

Mass poultry vaccination programmes lead to dramatic decline in Salmonella infections

Mass poultry vaccination programmes introduced to combat Salmonella infections have led to a dramatic fall in the number of cases since the late 1990s, according to a researcher at the University of Liverpool.

17 Jan 2013

Five flu-prevention tips from Kimberly-Clark Professional

This year's flu season has now been declared an epidemic, with a particularly dangerous strain that has hospitalized more than 3,700 people, according to the Centers for Disease Control and Prevention (CDC).

17 Jan 2013